Three for three: Hofseth Biocare gets NDI nod from FDA for bioactive peptides 29-Aug-2022 By Stephen Daniells Hofseth BioCare (HBC) has successfully achieved New Dietary Ingredient (NDI) status from the US Food and Drug Administration for its ProGo bioactive peptides, having already achieved this for its CalGo and OmeGo ingredients.
Guest article New Dietary Ingredients: Will FDA protect consumers from pirates and piggybackers? 05-Aug-2020 By Steve Mister, President & CEO, Council for Responsible Nutrition Why is it so hard to get FDA to enforce the law when it comes to NDIs?